132 related articles for article (PubMed ID: 24370024)
1. [Effects of matrine on the expression of NKG2D ligands in leukemia cells].
Ma LD; Lu XZ; Zhu ZC; Jiang LJ; Zhou M; Qian SX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1429-34. PubMed ID: 24370024
[TBL] [Abstract][Full Text] [Related]
2. [Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands].
Huang YX; Wang Y; Sun M; Zhou XY; Deng L; Guo KY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1329-32. PubMed ID: 19620045
[TBL] [Abstract][Full Text] [Related]
3. [Up-regulation of NKG2D ligand ULBP2 by matrine in K562 cells and the underlying molecular mechanisms].
Ma L; Zhu Z; Lu X; Jiang L; Zhou M; Qian S; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):438-42. PubMed ID: 24857216
[TBL] [Abstract][Full Text] [Related]
4. [NKG2D-mediated natural killer cell cytotoxicity against myeloid leukemia cells OUN-1].
Lu XZ; Cai XH; Ma LD; Chen BA
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):444-7. PubMed ID: 22967377
[TBL] [Abstract][Full Text] [Related]
5. [Expression and abscission of activated receptors and their ligands on/from NK cells in peripheral blood of patients with acute leukemia].
Fang XC; Liu HL; Sun ZM; Gui L; Geng LQ; Wang XB; Zhou M; Wang ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):436-40. PubMed ID: 20416183
[TBL] [Abstract][Full Text] [Related]
6. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8
Vadstrup K; Galsgaard ED; Jensen H; Lanier LL; Ryan JC; Chen SY; Nolan GP; Vester-Andersen MK; Pedersen JS; Gerwien J; Jensen T; Bendtsen F
Exp Mol Pathol; 2017 Aug; 103(1):56-70. PubMed ID: 28684217
[TBL] [Abstract][Full Text] [Related]
7. Matrine regulates immune functions to inhibit the proliferation of leukemic cells.
Zhang L; Zhang H; Zhu Z; Jiang L; Lu X; Zhou M; Sun X; He L; Bai Y; Ma L
Int J Clin Exp Med; 2015; 8(4):5591-600. PubMed ID: 26131142
[TBL] [Abstract][Full Text] [Related]
8. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
[TBL] [Abstract][Full Text] [Related]
11. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells.
Hedlund M; Nagaeva O; Kargl D; Baranov V; Mincheva-Nilsson L
PLoS One; 2011 Feb; 6(2):e16899. PubMed ID: 21364924
[TBL] [Abstract][Full Text] [Related]
12. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
Raneros AB; Minguela A; Rodriguez RM; Colado E; Bernal T; Anguita E; Mogorron AV; Gil AC; Vidal-Castiñeira JR; Márquez-Kisinousky L; Bulnes PD; Marin AM; Garay MCG; Suarez-Alvarez B; Lopez-Larrea C
Oncotarget; 2017 May; 8(19):31959-31976. PubMed ID: 28404876
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.
Fujita H; Hatanaka Y; Sutoh Y; Suzuki Y; Oba K; Hatanaka KC; Mitsuhashi T; Otsuka N; Fugo K; Kasahara M; Matsuno Y
J Histochem Cytochem; 2015 Mar; 63(3):217-27. PubMed ID: 25473094
[TBL] [Abstract][Full Text] [Related]
14. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma.
Wu X; Tao Y; Hou J; Meng X; Shi J
Neoplasia; 2012 Dec; 14(12):1178-89. PubMed ID: 23308050
[TBL] [Abstract][Full Text] [Related]
18. The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition.
Chaouat AE; Seliger B; Mandelboim O; Schmiedel D
Front Immunol; 2021; 12():714799. PubMed ID: 34721381
[TBL] [Abstract][Full Text] [Related]
19. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
[TBL] [Abstract][Full Text] [Related]
20. c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis.
Nanbakhsh A; Pochon C; Mallavialle A; Amsellem S; Bourhis JH; Chouaib S
Blood; 2014 Jun; 123(23):3585-95. PubMed ID: 24677544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
